| Associate Director, Strategy, Oncology Disease Area |
Cambridge (USA) |
Etats-Unis |
Biomedical Research |
Research |
BDL et planification stratégique |
27 Mai 2026 |
| Executive Director M&A Transactions |
Cambridge (USA) |
Etats-Unis |
Strategy & Growth |
Finance |
BDL et planification stratégique |
27 Mai 2026 |
| Executive Director M&A Transactions |
Basel (City) |
Suisse |
Strategy & Growth |
Finance |
BDL et planification stratégique |
27 Mai 2026 |
| Head of China C&BD |
Shanghai (Shanghai) |
Chine |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
26 Mai 2026 |
| VP, M&A Transactions |
Basel (City) |
Suisse |
Strategy & Growth |
Finance |
BDL et planification stratégique |
22 Mai 2026 |
| VP, M&A Transactions |
Cambridge (Massachusetts) |
Etats-Unis |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
22 Mai 2026 |
| AI Innovation Lead |
Hyderabad (Office) |
Inde |
People & Organization |
Human Resources |
BDL et planification stratégique |
20 Mai 2026 |
| Director, Portfolio & Product Strategy, NS |
East Hanover |
Etats-Unis |
US |
General Management |
BDL et planification stratégique |
18 Mai 2026 |
| Director, Portfolio & Product Strategy, NS |
East Hanover |
Etats-Unis |
US |
General Management |
BDL et planification stratégique |
18 Mai 2026 |
| Executive Director, Therapeutic Area Strategy, Oncology and Hematology |
East Hanover |
Etats-Unis |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
08 Mai 2026 |
| Director, Therapeutic Area Strategy, CRM |
Cambridge (USA) |
Etats-Unis |
Strategy & Growth |
General Management |
BDL et planification stratégique |
28 Avril 2026 |
| Director, Therapeutic Area Strategy, CRM |
Basel (City) |
Suisse |
Strategy & Growth |
General Management |
BDL et planification stratégique |
28 Avril 2026 |
| ED, US Business Development and Licensing, Commercial Mergers & Integrations |
East Hanover |
Etats-Unis |
US |
Strategic Planning & BD&L |
BDL et planification stratégique |
28 Avril 2026 |
| Director, Therapeutic Area Strategy, Immunology |
Basel (City) |
Suisse |
Strategy & Growth |
Other |
BDL et planification stratégique |
27 Avril 2026 |
| Director, Therapeutic Area Strategy, Immunology |
Cambridge (USA) |
Etats-Unis |
Strategy & Growth |
Other |
BDL et planification stratégique |
27 Avril 2026 |
| Therapeutic Area Strategy Director, Oncology & Hematology |
East Hanover |
Etats-Unis |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
27 Avril 2026 |
| Therapeutic Area Strategy Director, Oncology & Hematology |
Basel (City) |
Suisse |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
27 Avril 2026 |
| Executive Director, Therapeutic Area Strategy, Oncology and Hematology |
Basel (City) |
Suisse |
Strategy & Growth |
Strategic Planning & BD&L |
BDL et planification stratégique |
21 Avril 2026 |
| Executive Director, Portfolio & Product Strategy Theranostics |
Distant Employee - Distant Working Arrangement (DWA) (USA) |
Etats-Unis |
US |
General Management |
BDL et planification stratégique |
08 Avril 2026 |
| Head of New Product, International China |
Shanghai (Shanghai) |
Chine |
International |
General Management |
BDL et planification stratégique |
03 March 2026 |